Research Participation With Transgender and Gender-Diverse Youth
ConditionTransgender Persons
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-21
SponsorVirginia Commonwealth University
About this trial
Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access to research for transgender and gender-diverse youth and therefore, improve the representation of transgender and gender-diverse youth as research participants in research.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Gender identity different then sex assigned at birth
Between the ages 15-21 years
Disqualifiers
Gender identity the same as their sex assigned at birth
Younger than 15 years of age, and older than 21 years of age
Trial population
Transgender and gender-diverse adolescents
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Survey
Other interventionSurvey asking about sociodemographics, pediatric research participation, experience with research, gender minority stress and resilience, vaccine hesitancy, medical mistrust, and connectedness to the LGBT community
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Survey1 intervention
Trial outcomes
Primary outcomes
1
Quantitative Assessment of Pediatric Research Participation in Transgender Youth
The outcome will be the responses (agree or disagree) to the different items in the Pediatric Research Participation measure.
Time frame
through study completion, estimated to be 3 months2
Qualitative Assessment of Pediatric Research Participation in Transgender Youth
The investigators will implement qualitative analysis to explore transgender and gender-diverse youths experiences with research, and barriers and facilitators to participating in research. Specifically, the outcomes will be themes and supporting quotes.
Time frame
through study completion, estimated to be 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov